Conformis, Inc. Appoints Michael Fillion as Chief Operating Officer
April 01, 2022 17:00 ET
|
Conformis, Inc.
BILLERICA, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Michael Fillion has joined the Company as its Chief Operating Officer. “We are pleased to...
Conformis Partners with Synchrony to Offer CareCredit Financial Services to Orthopedic Patients
March 22, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), the pioneer and leader of fully personalized knee and hip replacement systems, today announced a strategic...
Conformis, Inc. Appoints Denise Pedulla as Chief Legal Officer and Corporate Secretary
March 14, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., March 14, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Denise Pedulla has joined the Company as its Chief Legal Officer and Corporate Secretary. “We...
Gary Fischetti nominated to join Conformis’ Board of Directors
March 11, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., March 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today that Gary P. Fischetti has been nominated to stand for election to the Company’s Board of...
Conformis, Inc. Reports Fourth Quarter and Year End 2021 Financial Results
March 02, 2022 16:05 ET
|
Conformis, Inc.
BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Suspends All Distribution Operations and Business Development in Russia
March 02, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., March 02, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced that it was suspending all distribution operations to Russia and any Russian-based entities for its...
New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1
February 28, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), the pioneer and leader of fully personalized orthopedic medical devices, today announced results of a published...
Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel
February 24, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in Upcoming Investor Conferences
February 18, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 2, 2022
January 20, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial...